SEC Form 4 · accession 0001465825-15-000003
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ashok G Nigalaye
Director
Period of report
May 21, 2015
Accepted (ET)
May 21, 2015 · 3:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 21, 2015 | C | 2,000,000 | $0.0625 | A | 40,442,232 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants | $0.0625 | May 21, 2015 | C | 2,000,000 | D | Apr 25, 2011 | Apr 25, 2018 | Common Stock | 2,000,000 | 2,000,000 | D |